Rebound effect of the allogenic T-cell response to donor and third-party lymphocytes after cyclosporine withdrawal in renal transplant recipients

Transplant Immunology

Volumn 6, Issue 4, 1998, Pages 261-264

  Creemers, P ^a   Pascoe, Md ^a   Pontin, Ar ^a   Kahn, D ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE;

ALLOGRAFT; ARTICLE; CADAVER; CLINICAL ARTICLE; DRUG WITHDRAWAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032417818     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(98)80016-6     Document Type: Article

References (12)

1. Jiang H, Suguo H, Takahara S, et al. Combined immunosuppressive effect of FK 506 and other immunosuppressive agents on PHA- and CD3- stimulated human lymphocyte proliferation in vivo. Transplant Proc. 23:1991;2933-2936.
2. Takdori K, Nio Y, Inoue K, et al. Effects of FK 506 on in vivo immunity in comparison to cyclosporine. Transplant Proc. 23:1991;2948-2949.
3. Li B, Sehajpal PK, Subramaniam A, Joseph A, Stenzel KH, Suthanthiran M. Inhibition of interleukin 2 receptor expression in normal human T cells by cyclosporine. Transplantation. 53:1992;146-151.
4. McCarthy SA, Mainwaring MS, Cains JS. Effects of FK 506 and Cyclosporine on T-cell tolerance; Inhibition of a 'protective' mechanism that regulates activation-induced apoptosis in developing thymocytes. Transplant Proc. 23:1991;2925-2927.
5. Erlanger BF. Do we know the site of action of cyclosporine? Immunol Today. 13:1992;487-490.
6. Merker M, Handschuhmacher RE. Uptake and nature of the intracellular binding of cyclosporine A in a murine thymoma cell line BW 5147. J Immunol. 132:1984;3064-3070.
7. Handschuhmacher RE, Harding M, Rice J, Drugge RJ, Speicher DW. Cyclophilin: a specific cytosolic binding protein of cyclosporine A. Science. 226:1984;544-547.
8. Flanagan WM, Corthesy B, Bram RJ, Crabtree GR. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature. 352:1991;803-807.
9. Opelz G. Superior long-term kidney graft survival in patients on maintenance immunosuppression with cyclosporin and azathioprine. Transplant Proc. 25:1993;1289-1290.
10. Frampton JE, Faulds D. Cyclosporin. A pharmacoeconomic evaluation of its use in renal transplantation. Pharma Econ. 4:1993;366-372.
11. Kasiske BL, Hein-Duthoy K, Ma JZ. Elective cyclosporin withdrawal after renal transplantation. J Am Med Ass. 269:1993;395-400.
12. Dewolf WC, O'Leary JJ, Ynis EJ. Cellular typing. Rose NR, Friedman H. Manual of clinical immunology. 1006-1025:1980;American Society for Microbiology, Washington, DC.